• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·KLRA
Share

Kailera Therapeutics, Inc. Stocks

$ 23.18Last Updated 01.06.2026

Issuer Rating

Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

$ 3.00B

$ 23.18
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

19.04.2026 22:00

Record listing since the 20th century and Ekman's roadshow: what's important about IPOs by April 19

17.04.2026 15:00

Kailera Therapeutics IPO: Shares of obesity drugmaker start trading

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Target Price

Favourable
6/7

The average target price of KLRA is 45 and suggests 96% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

03.06.2026 01:12

Virgin Galactic is having its worst 1d performance ever, following 204% 7d rally

03.06.2026 00:20

Investors began to see HPE stock as a bet on AI: report lifted the securities by 37%

02.06.2026 23:13

Victoria's Secret stock soared 45%. The sexy bet worked

02.06.2026 22:10

Musk recalled a 1,000-fold rise in Tesla's stock price. Can SpaceX rise in price the same way?

02.06.2026 21:48

Gold has regained its status as the largest reserve asset of central banks - ECB

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026